Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Februar 2025 08:45 ET | Quelle: Nutriband Inc.

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

U.S. Patent Office issues Notice of Allowance for new patent covering Nutriband's AVERSA™ technology
31. Dezember 2024 07:00 ET | Quelle: Nutriband Inc.

Nutriband Issues Letter to Shareholders

CEO Publishes Letter to Shareholders looking over achievements in 2024 and outlook for 2025
27. Dezember 2024 09:25 ET | Quelle: Nutriband Inc.

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Chinese Patent for AVERSA extended to Macao
04. Dezember 2024 09:00 ET | Quelle: Nutriband Inc.

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Inc. Q3 report and highlights
04. Dezember 2024 07:00 ET | Quelle: Nutriband Inc.

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

Serguei Melnik will present at the Noble Conference to discuss the companies latest advances with its AVERSA technology
27. November 2024 07:00 ET | Quelle: Nutriband Inc.

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nutriband Inc receives Hong Kong Patent Notice of Publication for its AVERSA patent application bringing the total number of countries covered to 46

Vorherige Seite